Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

85 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Microtubule-disrupting effects of gallium chloride in vitro.
Perchellet EM, Ladesich JB, Collery P, Perchellet JP. Perchellet EM, et al. Among authors: perchellet jp. Anticancer Drugs. 1999 Jun;10(5):477-88. doi: 10.1097/00001813-199906000-00008. Anticancer Drugs. 1999. PMID: 10477168
Induction of poly(ADP-ribose) polymerase-1 cleavage by antitumor triptycene bisquinones in wild-type and daunorubicin-resistant HL-60 cell lines.
Wang Y, Perchellet EM, Tamura M, Hua DH, Perchellet JP. Wang Y, et al. Among authors: perchellet em, perchellet jp. Cancer Lett. 2002 Dec 15;188(1-2):73-83. doi: 10.1016/s0304-3835(02)00493-7. Cancer Lett. 2002. PMID: 12406551
1,4-Anthraquinone: an anticancer drug that blocks nucleoside transport, inhibits macromolecule synthesis, induces DNA fragmentation, and decreases the growth and viability of L1210 leukemic cells in the same nanomolar range as daunorubicin in vitro.
Perchellet EM, Magill MJ, Huang X, Dalke DM, Hua DH, Perchellet JP. Perchellet EM, et al. Among authors: perchellet jp. Anticancer Drugs. 2000 Jun;11(5):339-52. doi: 10.1097/00001813-200006000-00004. Anticancer Drugs. 2000. PMID: 10912950
Antileukemic activity of synthetic daunomycinone derivatives bearing modifications in the glycosidic moiety.
Perchellet EM, Sperfslage BJ, McIlvain CJ, Aligiannis N, Pouli N, Marakos P, Skaltsounis AL, Perchellet JP. Perchellet EM, et al. Among authors: perchellet jp. Anticancer Res. 2001 Nov-Dec;21(6A):3957-67. Anticancer Res. 2001. PMID: 11911277
A synthetic triptycene bisquinone, which blocks nucleoside transport and induces DNA fragmentation, retains its cytotoxic efficacy in daunorubicin-resistant HL-60 cell lines.
Wang B, Wu M, Perchellet EM, McIlvain CJ, Sperfslage BJ, Huang X, Tamura M, Stephany HA, Hua DH, Perchellet JP. Wang B, et al. Among authors: perchellet em, perchellet jp. Int J Oncol. 2001 Dec;19(6):1169-78. doi: 10.3892/ijo.19.6.1169. Int J Oncol. 2001. PMID: 11713586
Synthetic 1,4-anthracenediones, which block nucleoside transport and induce DNA fragmentation, retain their cytotoxic efficacy in daunorubicin-resistant HL-60 cell lines.
Wu M, Wang B, Perchellet EM, Sperfslage BJ, Stephany HA, Hua DH, Perchellet JP. Wu M, et al. Among authors: perchellet em, perchellet jp. Anticancer Drugs. 2001 Nov;12(10):807-19. doi: 10.1097/00001813-200111000-00004. Anticancer Drugs. 2001. PMID: 11707648
Quinone isomers of the WS-5995 antibiotics: synthetic antitumor agents that inhibit macromolecule synthesis, block nucleoside transport, induce DNA fragmentation, and decrease the growth and viability of L1210 leukemic cells more effectively than ellagic acid and genistein in vitro.
Perchellet EM, Sperfslage BJ, Qabaja G, Jones GB, Perchellet JP. Perchellet EM, et al. Among authors: perchellet jp. Anticancer Drugs. 2001 Jun;12(5):401-17. doi: 10.1097/00001813-200106000-00002. Anticancer Drugs. 2001. PMID: 11395569
Triptycenes: a novel synthetic class of bifunctional anticancer drugs that inhibit nucleoside transport, induce DNA cleavage and decrease the viability of leukemic cells in the nanomolar range in vitro.
Perchellet EM, Magill MJ, Huang X, Brantis CE, Hua DH, Perchellet JP. Perchellet EM, et al. Among authors: perchellet jp. Anticancer Drugs. 1999 Sep;10(8):749-66. Anticancer Drugs. 1999. PMID: 10573208
Tricyclic pyrone analogs: a new synthetic class of bifunctional anticancer drugs that inhibit nucleoside transport, microtubule assembly, the viability of leukemic cells in vitro and the growth of solid tumors in vivo.
Perchellet EM, Ladesich JB, Magill MJ, Chen Y, Hua DH, Perchellet JP. Perchellet EM, et al. Among authors: perchellet jp. Anticancer Drugs. 1999 Jun;10(5):489-504. Anticancer Drugs. 1999. PMID: 10477169
Alterations in focal adhesion kinase activity and associated proteins during malignant conversion of mouse keratinocytes.
Newell SW, Perchellet JP, Perchellet EM, Ulug ET. Newell SW, et al. Among authors: perchellet jp, perchellet em. Mol Carcinog. 1999 May;25(1):73-83. doi: 10.1002/(sici)1098-2744(199905)25:1<73::aid-mc9>3.0.co;2-u. Mol Carcinog. 1999. PMID: 10331747
85 results
Jump to page
Feedback